Ontario · Registered charity
NEUROFIBROMATOSIS SOCIETY OF ONTARIO
NEUROFIBROMATOSIS SOCIETY OF ONTARIO (Ontario) receives grants from 13 organizations whose Canada Revenue Agency filings report C$124,994 to it, the largest being CANADAHELPS CANADON (C$56,581). 7 of them have funded it in more than one year.
- Revenue FY2024
- C$28k
- Funders on record
- 13
- Grants received
- C$125k
- Net assets
- —
What Neurofibromatosis Society of Ontario does
Ongoing programs
Provide information to NF members and public fund research outreach support programs for the NF comminity liaison.
As stated on its FY2024 T3010.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
88% of NEUROFIBROMATOSIS SOCIETY OF ONTARIO’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 5 reported years ran a deficit.
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base narrowed from 6 funders to 5 funders, grant income rose C$9k → C$13k.
From the CRA filings of NEUROFIBROMATOSIS SOCIETY OF ONTARIO’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.
How concentrated its funding is
NEUROFIBROMATOSIS SOCIETY OF ONTARIO leans on a few funders — its largest provides 45% of grant income and the top three 70%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NEUROFIBROMATOSIS SOCIETY OF ONTARIO.
Largest funder’s share by year: 2017 66% · 2018 71% · 2019 37% · 2020 59% · 2021 56% · 2022 72% · 2023 60% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.
How long its funders stay
50% of NEUROFIBROMATOSIS SOCIETY OF ONTARIO's funders are still giving 3 years after their first grant; 54% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
90% of NEUROFIBROMATOSIS SOCIETY OF ONTARIO's grant income comes from Ontario funders.
In-province vs out-of-province, by year
Funder regions come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.
Against its field
NEUROFIBROMATOSIS SOCIETY OF ONTARIO has grown faster than half of the 712 core health care nonprofits its size.
this organization peer median middle 50% of peers· 712 core health care nonprofits under $100k, FY2024
Read directly from this organization’s own T3010 return, as neutral context.
Governance
Questions and answers
- Who funds NEUROFIBROMATOSIS SOCIETY OF ONTARIO?
- NEUROFIBROMATOSIS SOCIETY OF ONTARIO (Ontario) receives grants from 13 organizations whose Canada Revenue Agency filings report C$124,994 to it, the largest being CANADAHELPS CANADON (C$56,581). 7 of them have funded it in more than one year.
- How many funders does NEUROFIBROMATOSIS SOCIETY OF ONTARIO have?
- Canada Revenue Agency filings report 13 organizations giving C$124,994 in grants to NEUROFIBROMATOSIS SOCIETY OF ONTARIO, 7 of which have funded it in more than one year.
- Who is the largest funder of NEUROFIBROMATOSIS SOCIETY OF ONTARIO?
- CANADAHELPS CANADON is the largest funder on record, with C$56,581 in grants. The full list of funders is on this page.
- How can an organization like NEUROFIBROMATOSIS SOCIETY OF ONTARIO find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Ontario.
These figures are read directly from the CRA's published T3010 data: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 13 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · View the T3010 on the CRA register